Tagged with GI

New US ‘Biosecure Act’ to Target Chinese Biotechs WuXi and BGI
China Pharma News: US Bill Pinpoints WuXi as “Foreign Adversary Biotech;” Novartis Acquires SanReno
Alexandre Leiria – Head of Life Sciences, Healthcare and Manufacturing, Capgemini Portugal
Ajit Singh – Chairman, ACG
Belgium’s EU Council Presidency Priorities for Healthcare & Pharma
China Pharma News: AstraZeneca Acquires Gracell Biotech; MGI Tech Bets on Australia
Indu Bhushan – Former CEO, Ayushman Bharat
China Pharma News: Aspen Buys Sandoz China; WuXi Biologics Stocks Take a Plunge
AstraZeneca Bets on Unified Clinical Trials with Healthtech Evinova
Digital Transformation: 3 Insights from UCB CEO Jean-Christophe Tellier
HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?
Bettina Bauer – Vice President, Global Commercial Product Strategy, HIV, COVID-19 & Emerging Viruses, Gilead Sciences
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here